Cell Death Discovery,
Journal Year:
2025,
Volume and Issue:
11(1)
Published: Feb. 20, 2025
Abstract
Brain
endothelial
cell
(bEC)
dysfunction
is
the
main
factor
of
blood-brain
barrier
(BBB)
breakdown,
which
triggers
a
vicious
cycle
aggravating
traumatic
brain
injury
(TBI)
pathogenesis.
Previous
studies
have
revealed
that
neutrophil
extracellular
traps
(NETs)
released
by
neutrophils
can
lead
to
BBB
disruption,
but
there
lack
research
on
underlying
mechanisms
after
TBI.
Here,
excessive
NETs
were
found
in
both
contused
tissue
and
circulation
following
We
could
activate
TLR4/NF-κB
pathway
induce
bEC
pyroptosis,
led
disruption
During
this
process,
ninjurin-1
(NINJ1)
was
activated
pyroptotic
bECs,
it
mediated
release
high
mobility
group
box
1
protein
(HMGB1)
via
plasma
membrane
rupture
(PMR)
promote
NET
formation.
NINJ1-mediated
HMGB1
aggravated
accumulation
forming
circle
Knockdown
NINJ1
rescued
formation,
attenuated
leakage,
improved
neurological
outcomes
may
represent
promising
target
for
alleviating
NET-induced
destruction
other
related
injuries
Journal of Neuroinflammation,
Journal Year:
2023,
Volume and Issue:
20(1)
Published: Sept. 30, 2023
Neuroinflammation
is
one
of
the
most
important
pathogeneses
in
secondary
brain
injury
after
traumatic
(TBI).
Neutrophil
extracellular
traps
(NETs)
forming
neutrophils
were
found
throughout
tissue
TBI
patients
and
elevated
plasma
NET
biomarkers
correlated
with
worse
outcomes.
However,
biological
function
underlying
mechanisms
NETs
TBI-induced
neural
damage
are
not
yet
fully
understood.
Here,
we
used
Cl-amidine,
a
selective
inhibitor
to
investigate
role
TBI.Controlled
cortical
impact
model
was
performed
establish
TBI.
2'3'-cGAMP
(an
activator
stimulating
Interferon
genes
(STING)),
C-176
(a
STING
inhibitor),
Kira6
[a
selectively
phosphorylated
inositol-requiring
enzyme-1
alpha
[IRE1α]
inhibitor]
administrated
explore
mechanism
by
which
promote
neuroinflammation
neuronal
apoptosis
Peptidyl
arginine
deiminase
4
(PAD4),
an
essential
enzyme
for
neutrophil
trap
formation,
overexpressed
adenoviruses
cortex
mice
1
day
before
The
short-term
neurobehavior
tests,
magnetic
resonance
imaging
(MRI),
laser
speckle
contrast
(LSCI),
Evans
blue
extravasation
assay,
Fluoro-Jade
C
(FJC),
TUNEL,
immunofluorescence,
enzyme-linked
immunosorbent
assay
(ELISA),
western
blotting,
quantitative-PCR
this
study.Neutrophils
form
presenting
circulation
at
3
days
Cl-amidine
treatment
improved
neurological
functions,
reduced
cerebral
lesion
volume,
edema,
restored
blood
flow
(CBF)
In
addition,
exerted
neuroprotective
effects
attenuating
BBB
disruption,
inhibiting
immune
cell
infiltration,
alleviating
death
Moreover,
inhibited
microglia/macrophage
pro-inflammatory
polarization
promoted
anti-inflammatory
Mechanistically,
ligand
abolished
neuroprotection
via
IRE1α/ASK1/JNK
signaling
pathway
Importantly,
overexpression
PAD4
promotes
or
IRE1α
effectively
neurodestructive
TBI.Altogether,
first
demonstrate
that
inhibition
ameliorated
neuroinflammation,
apoptosis,
deficits
STING-dependent
Thus,
may
provide
promising
therapeutic
approach
early
management
Annual Review of Pathology Mechanisms of Disease,
Journal Year:
2024,
Volume and Issue:
19(1), P. 227 - 259
Published: Jan. 24, 2024
Infections,
cardiovascular
disease,
and
cancer
are
major
causes
of
disease
death
worldwide.
Neutrophils
inescapably
associated
with
each
these
health
concerns,
by
either
protecting
from,
instigating,
or
aggravating
their
impact
on
the
host.
However,
disorders
has
a
very
different
etiology,
understanding
how
neutrophils
contribute
to
them
requires
intricacies
this
immune
cell
type,
including
nonimmune
contributions
physiology
pathology.
Here,
we
review
some
intricacies,
from
basic
concepts
in
neutrophil
biology,
such
as
production
acquisition
functional
diversity,
variety
mechanisms
which
they
preventing
infections,
events,
cancer.
We
also
poorly
explored
aspects
promote
favoring
tissue
repair
discuss
discoveries
about
biology
inform
development
new
therapeutic
strategies.
Translational Stroke Research,
Journal Year:
2024,
Volume and Issue:
unknown
Published: May 14, 2024
Abstract
Stroke
in
China
is
distinguished
by
its
high
rates
of
morbidity,
recurrence,
disability,
and
mortality.
The
ultra-early
administration
rtPA
essential
for
restoring
perfusion
acute
ischemic
stroke,
though
it
concurrently
elevates
the
risk
hemorrhagic
transformation.
High-mobility
group
box
1
(HMGB1)
emerges
as
a
pivotal
player
neuroinflammation
after
brain
ischemia
ischemia–reperfusion.
Released
passively
necrotic
cells
actively
secreted,
including
direct
secretion
HMGB1
into
extracellular
space
packaging
intracellular
vesicles
immune
cells,
glial
platelets,
endothelial
represents
prototypical
damage-associated
molecular
pattern
(DAMP).
It
intricately
involved
pathogenesis
atherosclerosis,
thromboembolism,
detrimental
inflammation
during
early
phases
stroke.
Moreover,
significantly
contributes
to
neurovascular
remodeling
functional
recovery
later
stages.
Significantly,
mediates
transformation
facilitating
neuroinflammation,
directly
compromising
integrity
blood–brain
barrier,
enhancing
MMP9
through
interaction
with
rtPA.
As
systemic
inflammatory
factor,
also
implicated
post-stroke
depression
an
elevated
stroke-associated
pneumonia.
role
extends
influencing
polarizing
various
subtypes
cells.
This
includes
mediating
excitotoxicity
due
excitatory
amino
acids,
autophagy,
release,
NET
formation,
autocrine
trophic
pathways.
Given
multifaceted
role,
recognized
crucial
therapeutic
target
prognostic
marker
stroke
In
this
review,
we
summarize
structure
redox
properties,
pathways,
regulation
cell
activity,
pathophysiological
mechanisms
hemorrhage
HMGB1,
which
will
pave
way
developing
new
neuroprotective
drugs,
reduction
expansion
thrombolysis
time
window.
Frontiers in Immunology,
Journal Year:
2022,
Volume and Issue:
13
Published: Aug. 1, 2022
Platelets
are
well
characterized
for
their
indispensable
role
in
primary
hemostasis
to
control
hemorrhage.
Research
over
the
past
years
has
provided
a
substantial
body
of
evidence
demonstrating
that
platelets
also
participate
host
innate
immunity.
The
surface
expression
pattern
recognition
receptors,
such
as
TLR2
and
TLR4,
provides
with
ability
sense
bacterial
products
environment.
Platelet
α-granules
contain
microbicidal
proteins,
chemokines
growth
factors,
which
upon
release
may
directly
engage
pathogens
and/or
contribute
inflammatory
signaling.
Additionally,
platelet
interactions
neutrophils
enhance
neutrophil
activation
often
crucial
induce
sufficient
immune
response.
In
particular,
can
activate
form
extracellular
traps
(NETs).
This
specific
effector
function
is
by
expelling
chromatin
fibres
decorated
histones
antimicrobial
proteins
into
space
where
they
serve
trap
kill
pathogens.
Until
now,
mechanisms
signaling
pathways
between
inducing
NET
formation
still
not
fully
characterized.
NETs
were
detected
thrombotic
lesions
several
disease
backgrounds,
pointing
towards
an
interface
neutrophils,
thrombosis,
known
immunothrombosis.
negatively
charged
DNA
within
procoagulant
surface,
particular
NET-derived
platelets.
light
current
COVID-19
pandemic,
topic
immunothrombosis
become
more
relevant
than
ever,
majority
patients
display
thrombi
lung
capillaries
other
vascular
beds.
Furthermore,
be
found
tissues
associated
increased
mortality.
Here,
virus
infiltration
lead
cytokine
storm
potently
activates
leads
massive
formation.
resulting
presumably
coagulation
further
contributing
subsequent
emergence
microthrombi
pulmonary
capillaries.
this
review,
we
will
discuss
interplay
potential
alliance
influence
course
diseases.
A
better
understanding
underlying
molecular
identification
treatment
targets
utmost
importance
increase
patients'
survival
improve
clinical
outcome.
Frontiers in Immunology,
Journal Year:
2022,
Volume and Issue:
13
Published: Nov. 16, 2022
COVID-19
patients
have
a
high
incidence
of
thrombosis,
and
thromboembolic
complications
are
associated
with
severe
mortality.
disease
is
hyper-inflammatory
response
(cytokine
storm)
mediated
by
the
immune
system.
However,
role
inflammatory
in
thrombosis
remains
incompletely
understood.
In
this
review,
we
investigate
crosstalk
between
inflammation
context
COVID-19,
focusing
on
contributions
to
pathogenesis
propose
combined
use
anti-inflammatory
anticoagulant
therapeutics.
Under
conditions,
interactions
neutrophils
platelets,
platelet
activation,
monocyte
tissue
factor
expression,
microparticle
release,
phosphatidylserine
(PS)
externalization
as
well
complement
activation
collectively
involved
immune-thrombosis.
Inflammation
results
apoptosis
blood
cells,
leading
release
PS
cells
microparticles,
which
significantly
enhances
catalytic
efficiency
tenase
prothrombinase
complexes,
promotes
thrombin-mediated
fibrin
generation
local
clot
formation.
Given
risk
importance
antithrombotic
therapies
has
been
generally
recognized,
but
certain
deficiencies
treatment
gaps
remain.
Antiplatelet
drugs
not
combination
treatments,
thus
fail
dampen
procoagulant
activity.
Current
treatments
also
do
an
optimal
time
for
anticoagulation.
The
efficacy
depends
therapy
initiation.
best
early
possible
after
diagnosis,
ideally
stage
disease.
We
elaborate
mechanisms
long
COVID
complications,
including
persistent
inflammation,
endothelial
injury
dysfunction,
coagulation
abnormalities.
above-mentioned
contents
provide
therapeutic
strategies
further
improve
patient
outcomes.
ACS Nano,
Journal Year:
2023,
Volume and Issue:
17(18), P. 17845 - 17857
Published: Sept. 15, 2023
Brain
inflammation
is
regarded
as
one
of
the
leading
causes
that
aggravates
secondary
brain
injury
and
hinders
prognosis
ischemic
stroke.
After
stroke,
high
quantities
peripheral
neutrophils
are
recruited
to
lesions
release
neutrophil
extracellular
traps
(NETs),
aggravation
blood-brain
barrier
(BBB)
damage,
activation
microglia,
ultimate
neuronal
death.
Herein,
a
smart
multifunctional
delivery
system
has
been
developed
regulate
immune
disorders
in
brain.
Briefly,
Cl-amidine,
an
inhibitor
peptidylarginine
deiminase
4
(PAD4),
encapsulated
into
self-assembled
liposomal
nanocarriers
(C-Lipo/CA)
modified
by
reactive
oxygen
species
(ROS)-responsive
polymers
fibrin-binding
peptide
achieve
targeting
stimuli-responsive
drug.
In
mouse
model
cerebral
artery
occlusion/reperfusion
(MCAO),
C-Lipo/CA
can
suppress
NETs
process
(NETosis)
further
inhibit
cyclic
guanosine
monophosphate-adenosine
monophosphate
synthase-stimulator
interferon
genes
(cGAS-STING)
pathway
addition,
MCAO
mice
treated
with
significantly
mitigated
reperfusion
injury,
reduction
area
infarction
12.1%,
compared
saline
group
about
46.7%.
These
results
demonstrated
C-Lipo/CA,
which
integrated
microglia
regulation,
BBB
protection,
neuron
survival,
exerts
potential
therapy
strategy
maximize
ameliorating
mortality
Neurology International,
Journal Year:
2022,
Volume and Issue:
14(2), P. 391 - 405
Published: April 24, 2022
Stroke
is
a
fatal
morbidity
that
needs
emergency
medical
admission
and
immediate
attention.
COVID-19
ischemic
brain
damage
closely
associated
with
common
neurological
symptoms,
which
are
extremely
difficult
to
treat
medically,
risk
factors.
We
performed
literature
research
about
ischemia
in
Journal of Neuroinflammation,
Journal Year:
2023,
Volume and Issue:
20(1)
Published: Sept. 30, 2023
To
explore
the
association
of
systemic
inflammatory
index
(SIRI),
immune-inflammatory
(SII)
and
prognosis
(IPI)
with
90d
outcomes
in
patients
acute
ischemic
stroke
(AIS)
after
intravenous
thrombolysis.The
who
underwent
thrombolysis
were
enrolled
present
study
from
September
2019
to
December
2022.
According
relevant
blood
indexes
obtained
24
h
admission,
corresponding
values
SIRI,
SII
IPI
calculated.
The
correlation
among
SII,
IPI,
admission
NIHSS
scores
was
examined
by
Spearman
analysis.
ROC
curve
analysis
conducted
determine
optimal
cut-off
value
their
sensitivity
specificity
evaluate
predictive
on
for
poor
prognosis.
investigate
whether
high
independent
predictors
within
90
days,
variables
P-value
<
0.05
during
univariate
included
multivariate
analysis.Compared
good
outcome
group,
group
had
higher
SII.
showed
that
levels
significantly
correlated
score
(r
=
0.338,
0.356,
0.427,
respectively;
Ps
0.001).
Univariate
Multivariate
logistic
regression
revealed
as
risk
factors
90-day
(OR
1.09,
1.003
7.109,
respectively).High
are
AIS
undergoing
thrombolysis.
Journal of Thrombosis and Haemostasis,
Journal Year:
2023,
Volume and Issue:
21(9), P. 2569 - 2584
Published: April 11, 2023
COVID-19
severity
and
its
late
complications
continue
to
be
poorly
understood.
Neutrophil
extracellular
traps
(NETs)
form
in
acute
COVID-19,
likely
contributing
morbidity
mortality.This
study
evaluated
immunothrombosis
markers
a
comprehensive
cohort
of
recovered
patients,
including
the
association
NETs
with
long
COVID.One-hundred-seventy-seven
patients
were
recruited
from
clinical
cohorts
at
2
Israeli
centers:
(mild/moderate,
severe/critical),
convalescent
(recovered
COVID),
along
54
non-COVID
controls.
Plasma
was
examined
for
platelet
activation,
coagulation,
NETs.
Ex
vivo
NETosis
induction
capability
after
neutrophil
incubation
patient
plasma.Soluble
P-selectin,
factor
VIII,
von
Willebrand
factor,
4
significantly
elevated
versus
Myeloperoxidase
(MPO)-DNA
complex
levels
increased
only
severe
did
not
differentiate
between
severities
or
correlate
thrombotic
markers.
strongly
correlated
illness
severity/duration,
activation
markers,
coagulation
factors,
reduced
upon
dexamethasone
treatment
recovery.
Patients
COVID
maintained
higher
induction,
but
NET
fragments,
compared
patients.Increased
can
detected
COVID.
appears
more
sensitive
measurement
than
MPO-DNA
differentiating
disease
Ongoing
may
provide
insights
into
pathogenesis
serve
as
surrogate
marker
persistent
pathology.
This
emphasizes
need
explore
neutrophil-targeted
therapies
chronic
COVID-19.